● Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

Condition: Schizophrenia · Sponsor: Vanda Pharmaceuticals

PhasePhase 3

Planned participants400

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersNo

About this study

The purpose of this research is to evaluate the efficacy of dosing iloperidone long-acting injection (LAI) compared to placebo in preventing the exacerbation of symptoms in patients with schizophrenia.

This description comes directly from the study's public registry record.

Talk to the study team

Vanda Pharmaceuticals Inc. · 202-734-3400 · clinicaltrials@vandapharma.com

Always discuss trial participation with your own doctor first.

Locations (22)

Vanda Investigational Site	Rogers, Arkansas, United States	Recruiting
Vanda Investigational Site	Costa Mesa, California, United States	Recruiting
Vanda Investigational Site	Lemon Grove, California, United States	Recruiting
Vanda Investigational Site	Oceanside, California, United States	Recruiting
Vanda Investigational Site	Pico Rivera, California, United States	Recruiting
Vanda Investigational Site	San Diego, California, United States	Recruiting
Vanda Investigational Site	Walnut Creek, California, United States	Recruiting
Vanda Investigational Site	North Miami, Florida, United States	Recruiting
Vanda Investigational Site	Atlanta, Georgia, United States	Recruiting
Vanda Investigational Site	Peachtree Corners, Georgia, United States	Recruiting
Vanda Investigational Site	Chicago, Illinois, United States	Recruiting
Vanda Investigational Site	Flowood, Mississippi, United States	Recruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06961968